These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 34733102)

  • 21. Identification of biomarkers associated with diagnosis and prognosis of colorectal cancer patients based on integrated bioinformatics analysis.
    Chen L; Lu D; Sun K; Xu Y; Hu P; Li X; Xu F
    Gene; 2019 Apr; 692():119-125. PubMed ID: 30654001
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Screening the Cancer Genome Atlas Database for Genes of Prognostic Value in Acute Myeloid Leukemia.
    Ni J; Wu Y; Qi F; Li X; Yu S; Liu S; Feng J; Zheng Y
    Front Oncol; 2019; 9():1509. PubMed ID: 32039005
    [No Abstract]   [Full Text] [Related]  

  • 23. Identifying Potential Prognostic Markers for Muscle-Invasive Bladder Urothelial Carcinoma by Weighted Gene Co-Expression Network Analysis.
    Feng Y; Jiang Y; Wen T; Meng F; Shu X
    Pathol Oncol Res; 2020 Apr; 26(2):1063-1072. PubMed ID: 31011911
    [TBL] [Abstract][Full Text] [Related]  

  • 24. AUNIP Expression Is Correlated With Immune Infiltration and Is a Candidate Diagnostic and Prognostic Biomarker for Hepatocellular Carcinoma and Lung Adenocarcinoma.
    Ma C; Kang W; Yu L; Yang Z; Ding T
    Front Oncol; 2020; 10():590006. PubMed ID: 33363020
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical value of M1 macrophage-related genes identification in bladder urothelial carcinoma and
    Yu Y; Huang Y; Li C; Ou S; Xu C; Kang Z
    Front Genet; 2022; 13():1047004. PubMed ID: 36468020
    [No Abstract]   [Full Text] [Related]  

  • 26. Alternative splicing patterns reveal prognostic indicator in muscle-invasive bladder cancer.
    AZhaTi B; Wu G; Zhan H; Liang W; Song Z; Lu L; Xie Q
    World J Surg Oncol; 2022 Jul; 20(1):231. PubMed ID: 35820925
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Novel Biomarker Based on miRNA to Predict the Prognosis of Muscle-Invasive Bladder Urothelial Carcinoma.
    Feng Y; Feng Q; Xu L; Jiang Y; Meng F; Shu X
    J Oncol; 2019; 2019():2654296. PubMed ID: 31885571
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of immune-related genes as prognostic factors in bladder cancer.
    Zhu J; Wang H; Ma T; He Y; Shen M; Song W; Wang JJ; Shi JP; Wu MY; Liu C; Wang WJ; Huang YQ
    Sci Rep; 2020 Nov; 10(1):19695. PubMed ID: 33184436
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel immune-related prognostic index for predicting breast cancer overall survival.
    Yu X; Guo J; Zhou Q; Huang W; Xu C; Long X
    Breast Cancer; 2021 Mar; 28(2):434-447. PubMed ID: 33146847
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic significance of tumor-infiltrating immune cells in muscle-invasive bladder cancer.
    Peng YL; Wu ZS; Lu HM; Wei WS; Xiong LB; Yu CP; Liu ZF; Li XD; Jiang LJ; Li YH; Liu ZW; Zhang ZL; Zhou FJ
    Am J Transl Res; 2020; 12(10):6524-6536. PubMed ID: 33194049
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Novel Set of Immune-associated Gene Signature predicts Biochemical Recurrence in Localized Prostate Cancer Patients after Radical Prostatectomy.
    Luan JC; Zhang QJ; Zhao K; Zhou X; Yao LY; Zhang TT; Zeng TY; Xia JD; Song NH
    J Cancer; 2021; 12(12):3715-3725. PubMed ID: 33995646
    [No Abstract]   [Full Text] [Related]  

  • 32. [Construction of prognostic model and identification of prognostic biomarkers based on the expression of long non-coding RNA in bladder cancer via bioinformatics].
    Yang FL; Hong K; Zhao GJ; Liu C; Song YM; Ma LL
    Beijing Da Xue Xue Bao Yi Xue Ban; 2019 Aug; 51(4):615-622. PubMed ID: 31420610
    [TBL] [Abstract][Full Text] [Related]  

  • 33. NEAT1/MALAT1/XIST/PKD--Hsa-Mir-101-3p--DLGAP5 Axis as a Novel Diagnostic and Prognostic Biomarker Associated With Immune Cell Infiltration in Bladder Cancer.
    Rao X; Cao H; Yu Q; Ou X; Deng R; Huang J
    Front Genet; 2022; 13():892535. PubMed ID: 35873473
    [No Abstract]   [Full Text] [Related]  

  • 34. Comprehensive Analysis of Prognostic Markers for Acute Myeloid Leukemia Based on Four Metabolic Genes.
    Zhang Y; Ma S; Wang M; Shi W; Hu Y
    Front Oncol; 2020; 10():578933. PubMed ID: 33117716
    [No Abstract]   [Full Text] [Related]  

  • 35. Identification of the prognostic value of ferroptosis-related gene signature in breast cancer patients.
    Wang D; Wei G; Ma J; Cheng S; Jia L; Song X; Zhang M; Ju M; Wang L; Zhao L; Xin S
    BMC Cancer; 2021 May; 21(1):645. PubMed ID: 34059009
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Exploration of a Robust and Prognostic Immune Related Gene Signature for Cervical Squamous Cell Carcinoma.
    Zuo Z; Xiong J; Zeng C; Jiang Y; Xiong K; Tao H; Guo Y
    Front Mol Biosci; 2021; 8():625470. PubMed ID: 33748188
    [No Abstract]   [Full Text] [Related]  

  • 37. Identification of an Immune-Related Long Noncoding RNA Pairs Model to Predict Survival and Immune Features in Gastric Cancer.
    Song S; Liu S; Wei Z; Jin X; Mao D; He Y; Li B; Zhang C
    Front Cell Dev Biol; 2021; 9():726716. PubMed ID: 34621744
    [No Abstract]   [Full Text] [Related]  

  • 38. A TP53-Associated Immune Prognostic Signature for the Prediction of Overall Survival and Therapeutic Responses in Muscle-Invasive Bladder Cancer.
    Wu X; Lv D; Cai C; Zhao Z; Wang M; Chen W; Liu Y
    Front Immunol; 2020; 11():590618. PubMed ID: 33391264
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification and Validation of Stromal Immunotype Predict Survival and Benefit from Adjuvant Chemotherapy in Patients with Muscle-Invasive Bladder Cancer.
    Fu H; Zhu Y; Wang Y; Liu Z; Zhang J; Xie H; Fu Q; Dai B; Ye D; Xu J
    Clin Cancer Res; 2018 Jul; 24(13):3069-3078. PubMed ID: 29514839
    [No Abstract]   [Full Text] [Related]  

  • 40. A model of seven immune checkpoint-related genes predicting overall survival for head and neck squamous cell carcinoma.
    Song D; Tian J; Han X; Li X
    Eur Arch Otorhinolaryngol; 2021 Sep; 278(9):3467-3477. PubMed ID: 33449165
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.